Close Menu

Agilent

LCS has entered a market varyingly referred to as sequence capture, target enrichment, and sequence enrichment. While the firms playing in this application area cannot agree on a name for it, they all agree that the market has the potential to become, in LCS' words, "very large."

The firm will use the undisclosed amount to optimize the protocols for its genomic-selection application and to start building a sales and marketing force that "will become more visible in the second half of this year," CEO Fred Dom said.

In Print: Mar 3, 2009

Premium

Microarray-Related Papers of Note, February 2009

New Products: Feb 26, 2009

Premium

Agilent, GWC Technologies, Pall Life Sciences, AnaSpec

Included is a patent for calibrating and processing MS data, and one for a method and device for extracting an analyte.

Both companies are offering users of second-generation sequencing systems new tools to select portions of the genome for targeted resequencing but have optimized their products for different sequencing platforms.

Researchers from the Murdoch Childrens Research Institute in Parkville, Australia, investigated the feasibility of replacing "time-consuming, locus-specific testing for specific microdeletion and microduplication syndromes with microarray analysis." Study co-author Howard Slater spoke with BioArray News about the paper.

BioArray Briefs: 2009.02.24

Premium

Signature Genomic Labs, HTG, CRL Global Services, Decode Genetics, Kreatech, BioMicro, Agilent, Scienion

Migrations: Feb 20, 2009

Premium

Patrick Kelly

Pages

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.